Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of Entecavir Plus Tenofovir in Chronic Hepatitis B
2007-001269-14Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Chronic Hepatitis B (CHB) comparing Entecavir + Tenofovir with Adefovir + Lamivudine (2 arms). Primary endpoints: Primary antiviral efficacy endpoint and Primary safety endpoint. Started Mar 2008; status: completed.
02
Drugs
entecavirtenofovir disoproxil fumarateadefovir dipivoxillamivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2007-001269-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001269-14.